Clinical, Immunological, and Molecular Features of Severe Combined Immune Deficiency: A Multi-Institutional Experience From India.
BCG
India
hematopoietic stem cell transplantation
newborn screening
severe combined immune deficiency
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
19
10
2020
accepted:
17
12
2020
entrez:
25
2
2021
pubmed:
26
2
2021
medline:
23
6
2021
Statut:
epublish
Résumé
Severe Combined Immune Deficiency (SCID) is an inherited defect in lymphocyte development and function that results in life-threatening opportunistic infections in early infancy. Data on SCID from developing countries are scarce. To describe clinical and laboratory features of SCID diagnosed at immunology centers across India. A detailed case proforma in an Excel format was prepared by one of the authors (PV) and was sent to centers in India that care for patients with primary immunodeficiency diseases. We collated clinical, laboratory, and molecular details of patients with clinical profile suggestive of SCID and their outcomes. Twelve (12) centers provided necessary details which were then compiled and analyzed. Diagnosis of SCID/combined immune deficiency (CID) was based on 2018 European Society for Immunodeficiencies working definition for SCID. We obtained data on 277 children; 254 were categorized as SCID and 23 as CID. Male-female ratio was 196:81. Median (inter-quartile range) age of onset of clinical symptoms and diagnosis was 2.5 months (1, 5) and 5 months (3.5, 8), respectively. Molecular diagnosis was obtained in 162 patients - We document an exponential rise in number of cases diagnosed to have SCID over the last 10 years, probably as a result of increasing awareness and improvement in diagnostic facilities at various centers in India. We suspect that these numbers are just the tip of the iceberg. Majority of patients with SCID in India are probably not being recognized and diagnosed at present. Newborn screening for SCID is the need of the hour. Easy access to pediatric HSCT services would ensure that these patients are offered HSCT at an early age.
Sections du résumé
Background
Severe Combined Immune Deficiency (SCID) is an inherited defect in lymphocyte development and function that results in life-threatening opportunistic infections in early infancy. Data on SCID from developing countries are scarce.
Objective
To describe clinical and laboratory features of SCID diagnosed at immunology centers across India.
Methods
A detailed case proforma in an Excel format was prepared by one of the authors (PV) and was sent to centers in India that care for patients with primary immunodeficiency diseases. We collated clinical, laboratory, and molecular details of patients with clinical profile suggestive of SCID and their outcomes. Twelve (12) centers provided necessary details which were then compiled and analyzed. Diagnosis of SCID/combined immune deficiency (CID) was based on 2018 European Society for Immunodeficiencies working definition for SCID.
Results
We obtained data on 277 children; 254 were categorized as SCID and 23 as CID. Male-female ratio was 196:81. Median (inter-quartile range) age of onset of clinical symptoms and diagnosis was 2.5 months (1, 5) and 5 months (3.5, 8), respectively. Molecular diagnosis was obtained in 162 patients -
Conclusion
We document an exponential rise in number of cases diagnosed to have SCID over the last 10 years, probably as a result of increasing awareness and improvement in diagnostic facilities at various centers in India. We suspect that these numbers are just the tip of the iceberg. Majority of patients with SCID in India are probably not being recognized and diagnosed at present. Newborn screening for SCID is the need of the hour. Easy access to pediatric HSCT services would ensure that these patients are offered HSCT at an early age.
Identifiants
pubmed: 33628209
doi: 10.3389/fimmu.2020.619146
pmc: PMC7897653
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
619146Informations de copyright
Copyright © 2021 Vignesh, Rawat, Kumrah, Singh, Gummadi, Sharma, Kaur, Nameirakpam, Jindal, Suri, Gupta, Khadwal, Saikia, Minz, Sharma, Desai, Taur, Gowri, Pandrowala, Dalvi, Jodhawat, Kambli, Madkaikar, Bhattad, Ramprakash, CP, Jayaram, Sivasankaran, Munirathnam, Balaji, Rajendran, Aggarwal, Singh, Na, George, Mehta, Lashkari, Uppuluri, Raj, Bartakke, Gupta, Sreedharanunni, Ogura, Kato, Imai, Chan, Leung, Ohara, Nonoyama, Hershfield, Lau and Singh.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cell. 1993 Apr 9;73(1):147-57
pubmed: 8462096
J Clin Immunol. 2011 Apr;31(2):281-96
pubmed: 21184155
Front Immunol. 2016 Aug 16;7:314
pubmed: 27579027
Front Immunol. 2018 Apr 16;9:782
pubmed: 29713328
Adv Genet. 2001;43:103-88
pubmed: 11037300
J Clin Immunol. 2021 Feb;41(2):393-413
pubmed: 33225392
Eur J Hum Genet. 2009 Feb;17(2):205-12
pubmed: 18701881
Front Immunol. 2019 Jul 23;10:1567
pubmed: 31396204
Hum Genet. 1995 Oct;96(4):427-32
pubmed: 7557965
BMC Med Genet. 2009 Nov 13;10:116
pubmed: 19912631
Front Immunol. 2019 Feb 04;10:23
pubmed: 30778343
Blood. 1997 Mar 15;89(6):1968-77
pubmed: 9058718
Immunol Lett. 2019 Dec;216:70-78
pubmed: 31589898
Blood. 2018 Oct 25;132(17):1737-1749
pubmed: 30154114
J Investig Allergol Clin Immunol. 2014;24(3):184-91
pubmed: 25011356
J Clin Immunol. 2020 Jan;40(1):24-64
pubmed: 31953710
Blood. 2002 Sep 15;100(6):2145-52
pubmed: 12200379
Front Pediatr. 2019 Sep 18;7:373
pubmed: 31620409
Science. 1996 Oct 4;274(5284):97-9
pubmed: 8810255
Immunol Allergy Clin North Am. 2010 Feb;30(1):125-42
pubmed: 20113890
Nat Rev Dis Primers. 2015 Oct 29;1:15061
pubmed: 27189259
J Allergy Clin Immunol. 2012 Aug;130(2):539-42
pubmed: 22578971
Emerg Infect Dis. 2017 Oct;23(10):1664-1670
pubmed: 28930011
J Allergy Clin Immunol. 2013 Jun;131(6):1594-603
pubmed: 23522482
Front Immunol. 2019 Sep 11;10:2111
pubmed: 31572360
J Allergy Clin Immunol. 2014 Apr;133(4):1099-108
pubmed: 24290284
Clin Immunol. 2015 Dec;161(2):174-9
pubmed: 26255240
Eur J Pediatr. 2015 Sep;174(9):1183-8
pubmed: 25875249
Immunol Today. 1996 Nov;17(11):507-11
pubmed: 8961626
Clin Immunol. 2015 Dec;161(2):316-23
pubmed: 26117625
Hum Mutat. 1992;1(2):166-8
pubmed: 1284479
JAMA. 2014 Aug 20;312(7):729-38
pubmed: 25138334
J Med Case Rep. 2009 Apr 01;3:6799
pubmed: 19830125
N Engl J Med. 2008 May 8;358(19):2030-8
pubmed: 18463379
J Invest Dermatol. 2009 Feb;129(2):266-77
pubmed: 19148216
J Clin Immunol. 2013 Apr;33(3):526-39
pubmed: 23250629
J Clin Immunol. 2013 Nov;33(8):1310-6
pubmed: 24122030
Br J Dermatol. 1996 Jul;135(1):124-7
pubmed: 8776375
J Clin Pathol. 2018 May;71(5):425-435
pubmed: 28970295
J Biol Chem. 1988 Nov 5;263(31):16291-6
pubmed: 3182793
J Clin Immunol. 2018 Aug;38(6):646-655
pubmed: 30046960
Nat Immunol. 2002 Nov;3(11):1075-81
pubmed: 12368908
J Biol Chem. 1996 Jan 12;271(2):619-22
pubmed: 8557662
Blood. 2001 Jan 1;97(1):81-8
pubmed: 11133745
Allergol Int. 2006 Jun;55(2):115-9
pubmed: 17075247
Eur J Pediatr. 2005 May;164(5):311-4
pubmed: 15729559
Orphanet J Rare Dis. 2018 Apr 24;13(1):65
pubmed: 29690908
Hum Mutat. 1997;9(2):118-21
pubmed: 9067751
J Allergy Clin Immunol. 2018 Apr;141(4):1450-1458
pubmed: 28916186
J Clin Immunol. 2019 Apr;39(3):316-323
pubmed: 30924026
Indian Pediatr. 2014 Oct;51(10):819-26
pubmed: 25362016
J Clin Immunol. 2011 Oct;31(5):778-83
pubmed: 21732012
Am J Hum Genet. 1995 Sep;57(3):564-71
pubmed: 7668284
Front Immunol. 2020 Aug 13;11:1605
pubmed: 32903579
Int J Hematol. 2004 Nov;80(4):332-5
pubmed: 15615257
Front Immunol. 2017 Jul 12;8:808
pubmed: 28747913
J Allergy Clin Immunol. 2019 Jan;143(1):405-407
pubmed: 30193840
Cell. 1998 May 29;93(5):885-96
pubmed: 9630231
Blood. 1997 Nov 15;90(10):3996-4003
pubmed: 9354668
Hum Mutat. 2006 Dec;27(12):1174-84
pubmed: 16960852
Am J Hum Genet. 1991 Oct;49(4):878-85
pubmed: 1680289
J Clin Immunol. 2014 Apr;34(3):304-8
pubmed: 24481607
Clin Immunol. 2015 Jun;158(2):167-73
pubmed: 25869295
Front Immunol. 2019 Jun 11;10:1248
pubmed: 31244832